BUSINESSThe Marijuana Herald
NIH selects CBD for federal longevity-program pilot testing
The National Institute on Aging's Interventions Testing Program selected CBD for preliminary stability, absorption and toxicity testing before any larger mouse lifespan study. Oklahoma medical operators should view the selection as an early federal research signal, not evidence that CBD extends lifespan or treats age-related disease.
Published Oct 14, 2026
Read the full article at The Marijuana Herald#national#research#cbd#medical-cannabis
Read the original source
Leafy summaries provide industry context. Confirm details with The Marijuana Herald.